The global cardiogenic shock market is projected to grow from $3.57 billion in 2024 to $5.2 billion by 2030, driven by the rising prevalence of cardiovascular diseases (CVDs) and advancements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback